Susquehanna International Group’s VistaGen Therapeutics VTGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $231K | Buy |
115,368
+50,587
| +78% | +$101K | ﹤0.01% | 5377 |
|
|
2025
Q1 | $162K | Sell |
64,781
-31,125
| -32% | -$77.8K | ﹤0.01% | 5636 |
|
|
2024
Q4 | $283K | Buy |
95,906
+43,812
| +84% | +$129K | ﹤0.01% | 4827 |
|
|
2024
Q3 | $157K | Sell |
52,094
-13,013
| -20% | -$39.2K | ﹤0.01% | 4936 |
|
|
2024
Q2 | $227K | Sell |
65,107
-223,778
| -77% | -$779K | ﹤0.01% | 4571 |
|
|
2024
Q1 | $1.53M | Buy |
+288,885
| New | +$1.53M | ﹤0.01% | 2132 |
|
|
2023
Q4 | – | Sell |
-19,355
| Closed | -$101K | – | 6696 |
|
|
2023
Q3 | $101K | Buy |
19,355
+7,053
| +57% | +$37K | ﹤0.01% | 4920 |
|
|
2023
Q2 | $23K | Buy |
12,302
+8,294
| +207% | +$15.5K | ﹤0.01% | 5344 |
|
|
2023
Q1 | $15K | Buy |
4,008
+1,276
| +47% | +$4.77K | ﹤0.01% | 5661 |
|
|
2022
Q4 | $8.44K | Sell |
2,732
-3,277
| -55% | -$10.1K | ﹤0.01% | 5498 |
|
|
2022
Q3 | $27K | Buy |
6,009
+1,140
| +23% | +$5.12K | ﹤0.01% | 5657 |
|
|
2022
Q2 | $129K | Buy |
4,869
+682
| +16% | +$18.1K | ﹤0.01% | 4868 |
|
|
2022
Q1 | $156K | Sell |
4,187
-4,442
| -51% | -$166K | ﹤0.01% | 4970 |
|
|
2021
Q4 | $504K | Buy |
8,629
+2,008
| +30% | +$117K | ﹤0.01% | 3805 |
|
|
2021
Q3 | $544K | Buy |
6,621
+6,001
| +968% | +$493K | ﹤0.01% | 3576 |
|
|
2021
Q2 | $59K | Sell |
620
-7,796
| -93% | -$742K | ﹤0.01% | 5141 |
|
|
2021
Q1 | $538K | Buy |
+8,416
| New | +$538K | ﹤0.01% | 3758 |
|
|
2020
Q2 | – | Sell |
-660
| Closed | -$9K | – | 4996 |
|
|
2020
Q1 | $9K | Buy |
660
+204
| +45% | +$2.78K | ﹤0.01% | 4429 |
|
|
2019
Q4 | $9K | Sell |
456
-16
| -3% | -$316 | ﹤0.01% | 3901 |
|
|
2019
Q3 | $15K | Buy |
+472
| New | +$15K | ﹤0.01% | 4317 |
|
|
2018
Q3 | – | Sell |
-2,416
| Closed | -$99K | – | 4773 |
|
|
2018
Q2 | $99K | Buy |
+2,416
| New | +$99K | ﹤0.01% | 3290 |
|
|
2018
Q1 | – | Sell |
-27,810
| Closed | -$926K | – | 4597 |
|
|
2017
Q4 | $926K | Buy |
+27,810
| New | +$926K | ﹤0.01% | 1851 |
|